BCM
IMA

Bridgeway Capital Management’s ImageneBio Inc IMA Stock Holding History

Bridgeway Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,774
Closed -$104K – 1248
2025
Q3 		$104K Sell
12,774
-1
-0% -$13 ﹤0.01% 1107
2025
Q2 		$205K Hold
12,775
– – ﹤0.01% 958
2025
Q1 		$196K Sell
12,775
-42
-0.3% -$724 ﹤0.01% 930
2024
Q4 		$252K Sell
12,817
-383
-3% -$7.74K 0.01% 958
2024
Q3 		$274K Buy
13,200
+6,342
+92% +$128K 0.01% 996
2024
Q2 		$136K Hold
6,858
– – ﹤0.01% 1129
2024
Q1 		$117K Sell
6,858
-5,105
-43% -$93K ﹤0.01% 1191
2023
Q4 		$283K Buy
11,963
+2,409
+25% +$78.5K 0.01% 1071
2023
Q3 		$496K Hold
9,554
– – 0.01% 871
2023
Q2 		$752K Hold
9,554
– – 0.02% 799
2023
Q1 		$396K Buy
9,554
+2,083
+28% +$95.7K 0.01% 937
2022
Q4 		$238K Sell
7,471
-179
-2% -$5.72K 0.01% 1044
2022
Q3 		$326K Buy
7,650
+6,567
+606% +$380K 0.01% 1012
2022
Q2 		$58K Buy
+1,083
New +$59.7K ﹤0.01% 1273

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Bridgeway Capital Management's IMA Position: Q4 2025 in Review

Bridgeway Capital Management sold out of ImageneBio Inc (IMA) in Q4 2025, closing a stake of 12,774 shares — an estimated $104K sold.

Bridgeway Capital Management first reported a position in IMA in Q2 2022 and held it in 14 quarters. The position peaked at $752K in Q2 2023. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

  • Bridgeway Capital Management reported no remaining ImageneBio Inc position as of Q4 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,774 ImageneBio Inc shares in Q4 2025, an estimated $104K.
  • Bridgeway Capital Management first reported a position in ImageneBio Inc in Q2 2022 and held it in 14 quarters.
  • Bridgeway Capital Management's ImageneBio Inc position peaked at $752K in Q2 2023.
  • 41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Bridgeway Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.